VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,283,193 | +330.3% | 136,947 | +968.6% | 0.01% | +350.0% |
| Q1 2023 | $298,205 | -39.4% | 12,815 | -34.1% | 0.00% | -33.3% |
| Q4 2022 | $492,457 | -75.8% | 19,457 | -81.6% | 0.00% | -72.7% |
| Q3 2022 | $2,034,000 | -51.9% | 105,507 | -36.4% | 0.01% | -57.7% |
| Q2 2022 | $4,227,000 | +2.4% | 165,941 | +3.4% | 0.03% | -25.7% |
| Q1 2022 | $4,128,000 | +8.5% | 160,503 | +76.6% | 0.04% | -2.8% |
| Q4 2021 | $3,806,000 | +1392.5% | 90,899 | +1450.1% | 0.04% | +1100.0% |
| Q3 2021 | $255,000 | -83.0% | 5,864 | -81.5% | 0.00% | -82.4% |
| Q2 2021 | $1,499,000 | +81.7% | 31,706 | +96.9% | 0.02% | +54.5% |
| Q1 2021 | $825,000 | – | 16,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |